
Ibrahim D. Bori
Examiner (ID: 18672, Phone: (571)270-7020 , Office: P/1629 )
| Most Active Art Unit | 1629 |
| Art Unit(s) | 1629 |
| Total Applications | 763 |
| Issued Applications | 313 |
| Pending Applications | 85 |
| Abandoned Applications | 385 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18224422
[patent_doc_number] => 20230063416
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => Polytherapy Modulating Cathelicidin Gene Expression Modulation for The Treatment of Alzheimer's Disease and Other Conditions
[patent_app_type] => utility
[patent_app_number] => 18/045793
[patent_app_country] => US
[patent_app_date] => 2022-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24882
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18045793
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/045793 | Polytherapy Modulating Cathelicidin Gene Expression Modulation for The Treatment of Alzheimer's Disease and Other Conditions | Oct 10, 2022 | Pending |
Array
(
[id] => 18184382
[patent_doc_number] => 20230045112
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => DISULFIRAM AND OTHER REDOX-RELATED COMPOSITIONS FOR BRAIN TUMORS
[patent_app_type] => utility
[patent_app_number] => 17/956249
[patent_app_country] => US
[patent_app_date] => 2022-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18877
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17956249
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/956249 | DISULFIRAM AND OTHER REDOX-RELATED COMPOSITIONS FOR BRAIN TUMORS | Sep 28, 2022 | Pending |
Array
(
[id] => 20185837
[patent_doc_number] => 12396937
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-26
[patent_title] => Ointments for treating dry skin
[patent_app_type] => utility
[patent_app_number] => 17/945311
[patent_app_country] => US
[patent_app_date] => 2022-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 0
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17945311
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/945311 | Ointments for treating dry skin | Sep 14, 2022 | Issued |
Array
(
[id] => 18496059
[patent_doc_number] => 20230218595
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => COMBINATION THERAPY USING ENANTIOPURE, OXY-SUBSTITUTED, DEUTERIUM-ENRICHED 5-(BENZYL)-5-DEUTERO-THIAZOLIDINE-2,4-DIONES FOR TREATMENT OF MEDICAL DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/882949
[patent_app_country] => US
[patent_app_date] => 2022-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20384
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17882949
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/882949 | COMBINATION THERAPY USING ENANTIOPURE, OXY-SUBSTITUTED, DEUTERIUM-ENRICHED 5-(BENZYL)-5-DEUTERO-THIAZOLIDINE-2,4-DIONES FOR TREATMENT OF MEDICAL DISORDERS | Aug 7, 2022 | Abandoned |
Array
(
[id] => 20127877
[patent_doc_number] => 12370177
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-29
[patent_title] => Compounds for treating brain cancer
[patent_app_type] => utility
[patent_app_number] => 17/874621
[patent_app_country] => US
[patent_app_date] => 2022-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 20
[patent_no_of_words] => 3952
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17874621
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/874621 | Compounds for treating brain cancer | Jul 26, 2022 | Issued |
Array
(
[id] => 20127877
[patent_doc_number] => 12370177
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-29
[patent_title] => Compounds for treating brain cancer
[patent_app_type] => utility
[patent_app_number] => 17/874621
[patent_app_country] => US
[patent_app_date] => 2022-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 20
[patent_no_of_words] => 3952
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17874621
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/874621 | Compounds for treating brain cancer | Jul 26, 2022 | Issued |
Array
(
[id] => 20185835
[patent_doc_number] => 12396935
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-26
[patent_title] => Reduced odor formaldehyde-containing antiseptic lotion
[patent_app_type] => utility
[patent_app_number] => 18/580809
[patent_app_country] => US
[patent_app_date] => 2022-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 442
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18580809
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/580809 | Reduced odor formaldehyde-containing antiseptic lotion | Jul 25, 2022 | Issued |
Array
(
[id] => 20303430
[patent_doc_number] => 12449415
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-21
[patent_title] => Diagnostics
[patent_app_type] => utility
[patent_app_number] => 17/867792
[patent_app_country] => US
[patent_app_date] => 2022-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 11
[patent_no_of_words] => 7729
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 159
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17867792
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/867792 | Diagnostics | Jul 18, 2022 | Issued |
Array
(
[id] => 19423696
[patent_doc_number] => 12083087
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-10
[patent_title] => Aqueous formulation comprising paracetamol and ibuprofen
[patent_app_type] => utility
[patent_app_number] => 17/867370
[patent_app_country] => US
[patent_app_date] => 2022-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9001
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17867370
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/867370 | Aqueous formulation comprising paracetamol and ibuprofen | Jul 17, 2022 | Issued |
Array
(
[id] => 18149680
[patent_doc_number] => 20230023537
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => DELIVERY SYSTEMS FOR CONTROLLED DRUG RELEASE
[patent_app_type] => utility
[patent_app_number] => 17/831710
[patent_app_country] => US
[patent_app_date] => 2022-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31148
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17831710
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/831710 | Delivery systems for controlled drug release | Jun 2, 2022 | Issued |
Array
(
[id] => 17865357
[patent_doc_number] => 20220288092
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-15
[patent_title] => Aqueous Nebulization Composition
[patent_app_type] => utility
[patent_app_number] => 17/826602
[patent_app_country] => US
[patent_app_date] => 2022-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39958
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17826602
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/826602 | Aqueous nebulization composition | May 26, 2022 | Issued |
Array
(
[id] => 17865474
[patent_doc_number] => 20220288209
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-15
[patent_title] => METHOD FOR INDUCING TUMOR REGRESSION
[patent_app_type] => utility
[patent_app_number] => 17/752676
[patent_app_country] => US
[patent_app_date] => 2022-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11906
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17752676
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/752676 | Method for inducing tumor regression | May 23, 2022 | Issued |
Array
(
[id] => 18302088
[patent_doc_number] => 11623980
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-04-11
[patent_title] => Hybrid mycelial cellulose sheet and preparation thereof
[patent_app_type] => utility
[patent_app_number] => 17/752648
[patent_app_country] => US
[patent_app_date] => 2022-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 1643
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17752648
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/752648 | Hybrid mycelial cellulose sheet and preparation thereof | May 23, 2022 | Issued |
Array
(
[id] => 17849790
[patent_doc_number] => 20220279831
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => COMPOSITIONS, KITS AND METHODS FOR NUTRITION SUPPLEMENTATION
[patent_app_type] => utility
[patent_app_number] => 17/750969
[patent_app_country] => US
[patent_app_date] => 2022-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22403
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 244
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17750969
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/750969 | COMPOSITIONS, KITS AND METHODS FOR NUTRITION SUPPLEMENTATION | May 22, 2022 | Abandoned |
Array
(
[id] => 18900663
[patent_doc_number] => 20240016148
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-18
[patent_title] => METHODS FOR POTENTIATING A BIOCIDE
[patent_app_type] => utility
[patent_app_number] => 17/749312
[patent_app_country] => US
[patent_app_date] => 2022-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6711
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17749312
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/749312 | METHODS FOR POTENTIATING A BIOCIDE | May 19, 2022 | Abandoned |
Array
(
[id] => 19372860
[patent_doc_number] => 12064399
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-20
[patent_title] => Use of cannabinoids in the treatment of epilepsy
[patent_app_type] => utility
[patent_app_number] => 17/744224
[patent_app_country] => US
[patent_app_date] => 2022-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6489
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17744224
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/744224 | Use of cannabinoids in the treatment of epilepsy | May 12, 2022 | Issued |
Array
(
[id] => 17928293
[patent_doc_number] => 20220323418
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-13
[patent_title] => COMBINATION THERAPY
[patent_app_type] => utility
[patent_app_number] => 17/662866
[patent_app_country] => US
[patent_app_date] => 2022-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15985
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17662866
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/662866 | Method for treating inflammatory disorders | May 10, 2022 | Issued |
Array
(
[id] => 17958577
[patent_doc_number] => 20220339157
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-27
[patent_title] => Formulations/Compositions Comprising a BTK Inhibitor
[patent_app_type] => utility
[patent_app_number] => 17/736305
[patent_app_country] => US
[patent_app_date] => 2022-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23016
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17736305
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/736305 | Formulations/Compositions Comprising a BTK Inhibitor | May 3, 2022 | Pending |
Array
(
[id] => 17958577
[patent_doc_number] => 20220339157
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-27
[patent_title] => Formulations/Compositions Comprising a BTK Inhibitor
[patent_app_type] => utility
[patent_app_number] => 17/736305
[patent_app_country] => US
[patent_app_date] => 2022-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23016
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17736305
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/736305 | Formulations/Compositions Comprising a BTK Inhibitor | May 3, 2022 | Pending |
Array
(
[id] => 17982539
[patent_doc_number] => 20220348575
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-03
[patent_title] => LSD SALT CRYSTAL FORMS
[patent_app_type] => utility
[patent_app_number] => 17/729205
[patent_app_country] => US
[patent_app_date] => 2022-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15630
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -49
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17729205
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/729205 | LSD SALT CRYSTAL FORMS | Apr 25, 2022 | Pending |